Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Explore practical smart money moves that can elevate your financial situation in everyday life. Start making informed choices now.
21,657 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Two industrial names sit at the center of the rare-earth supply story: MP Materials and TMC The Metals Company. This ...
In volatile markets, pulling back can create buying opportunities. This article highlights three growth stocks to buy...
A new global liveability ranking places a major city at the bottom in 2026, triggering concerns about investment, hou...
VanEck's NLR ETF blends uranium miners, enrichers and reactor operators, trading at 0.61%, as investors seek a balanc...
SoundHound AI is pursuing an enterprise voice AI niche built on data ownership and brand protection. This article bre...
This in-depth guide analyzes agilon health (agl) 2025 implications for investors. Learn the business model, key metri...
A bipartisan plan to extend a federal retirement-savings match to workers without employer plans surfaces, uniting a ...
Oracle’s 2026 story blends a sharp stock pullback with strong earnings momentum. Learn what’s driving the 18% drop, w...
Bittensor's TAO aims to blend AI training services with blockchain incentives. After a sharp rally, investors wonder ...
The 2027 cost-of-living adjustment is projected to be about 2.8%, continuing a pattern of modest bumps that often lag...
As Progyny gears up for 2026, investors want clarity on what drives progyny (pgny) 2026 earnings. This guide breaks d...